arrow_back Back Filing freshness 10-Q Q1 FY2026 SEC EDGAR

download Export Data

Indivior Pharmaceuticals, Inc.

INDV

$38.84 ▲ +0.18 (+0.47%) at close

18 Visible periods

29 Metrics

Peer-ranked Benchmarks

Price Chart

Health

Weak

Moderately Bullish

auto_awesome

Analytical Summary

Indivior Pharmaceuticals, Inc. shows strong fundamentals with top-quartile Profit Margin (%) and Debt to Equity. However, watch Return on Common Equity (%) which shows concerning trends. Overall, the data suggests a moderately positive outlook with manageable risks.

Market Cap $4.8B

Dividend Yield —

Revenue Growth 19.2% ↘

Op. Margin 43.2% ↗

ROIC 31.0% ↘

FCF / Share $-0.23

Trailing P/E 54.7x

Price / Book —

FCF Yield —

Debt / Equity -3.38

info Valuation on last close. End-of-day price, Aug 7, 2026.

18-Year Financial Trajectory

Quarterly

Metric Value Trend Year over Year Percentile

Revenue Total top-line sales

$317.00M

↑ +19.2% —

Net Income Profit after all expenses

$89.00M

↑ +89.4% —

Operating Margin Operating profit as % of sales

43.2%

↑ +91.0% 77th

FCF / Share Free cash flow per share

$-0.23

↑ +50.5% —

Long-Term Debt Long-term obligations

$486.00M

↑ +67.6% —

trending_up

Bullish Indicators

Debt to EquityDebt to Equity is in the top quartile (lower is better)
Operating Margin (%)Operating Margin (%) is in the top quartile
Profit Margin (%)Profit Margin (%) is in the top quartile

warning

Bearish Risks

Return on Common Equity (%)Return on Common Equity (%) is in the bottom quartile

Health Breakdown

Profitability ↓

Returns

Financial Health ↓

Cash Quality

Financial view

Statement lens

Choose the reporting cadence, isolate a period range, or search directly for a metric.

Cadence

Annual Quarterly

Range

→

📈 Is growth accelerating? 4 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Dec 31, 2023 10-Q ↗	Q2 FY2023 Dec 31, 2023 10-Q ↗	Q1 FY2023 Dec 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Dec 31, 2022 10-Q ↗	Q2 FY2022 Dec 31, 2022 10-Q ↗	Q1 FY2022 Dec 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗
Revenue Growth YoY (%)	19.2% Good ↑ Good Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+140%)	19.7% Good ↑ Good Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+147%)	2.3% Caution ↑ Caution Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-71%)	1.0% Caution Caution Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-87%)	-6.3% Weak Weak Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-179%)	—	—	—	—	—	—	—	—	—	—	—	—	—
EPS Growth YoY (%)	86.8% Excellent ↓ Excellent Declining Year-over-year change in earnings per share Optimal: > 10%	406.2% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	112.5% Excellent Excellent Year-over-year change in earnings per share Optimal: > 10%	N/M	-15.6% Weak Weak Year-over-year change in earnings per share Optimal: > 10%	—	—	—	N/M	100.0% Excellent Excellent Year-over-year change in earnings per share Optimal: > 10%	—	—	-206.7% Weak Weak Year-over-year change in earnings per share Optimal: > 10%	—	—	—	—	—
Net Income Growth YoY (%)	89.4% Excellent ↓ Excellent Declining Year-over-year change in net income	385.7% Excellent ↑ Excellent Improving Year-over-year change in net income	-23.0% Weak → Weak Stable Year-over-year change in net income	-23.0% Weak Weak Year-over-year change in net income	-23.0% Weak Weak Year-over-year change in net income	—	—	—	N/M	100.0% Excellent Excellent Year-over-year change in net income	—	—	-200.0% Weak Weak Year-over-year change in net income	—	—	—	—	—
FCF Growth YoY (%)	N/M	—	-1146.1% Weak Weak Year-over-year change in free cash flow	81.3% Excellent Excellent Year-over-year change in free cash flow	N/M	—	—	—	—	—	—	—	—	—	—	—	—	—

💰 Are margins durable? 5 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Dec 31, 2023 10-Q ↗	Q2 FY2023 Dec 31, 2023 10-Q ↗	Q1 FY2023 Dec 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Dec 31, 2022 10-Q ↗	Q2 FY2022 Dec 31, 2022 10-Q ↗	Q1 FY2022 Dec 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗
Operating Margin (%) (%)	43.2% Excellent ↑ Excellent Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Above avg (+188%)	22.6% Good ↑ Good Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Above avg (+51%)	13.7% Fair ↓ Fair Declining Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-9%)	23.8% Good ↑ Good Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Above avg (+59%)	24.8% Good ↑ Good Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Above avg (+65%)	15.4% Fair ↓ Fair Declining Operating income as a percentage of revenue Optimal: > 15% vs Sector: At sector avg	24.4% Good ↓ Good Declining Operating income as a percentage of revenue Optimal: > 15% vs Sector: Above avg (+63%)	25.1% Excellent Excellent Operating income as a percentage of revenue Optimal: > 15% vs Sector: Above avg (+67%)	26.4% Excellent Excellent Operating income as a percentage of revenue Optimal: > 15% vs Sector: Above avg (+76%)	—	—	—	—	—	—	—	—	—
Effective Tax Rate (%) (%)	22.6% Fair ↑ Fair Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	-25.9% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	-13.5% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	71.0% Weak ↑ Weak Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	18.6% Good ↓ Good Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	44.7% Weak ↑ Weak Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	15.1% Good → Good Stable Actual taxes paid relative to pre-tax income Optimal: 15-25%	15.1% Good Good Actual taxes paid relative to pre-tax income Optimal: 15-25%	15.1% Good Good Actual taxes paid relative to pre-tax income Optimal: 15-25%	—	—	—	13.1% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	33.3% Weak Weak Actual taxes paid relative to pre-tax income Optimal: 15-25%	—	—	50.0% Weak Weak Actual taxes paid relative to pre-tax income Optimal: 15-25%	—
Profit Margin (%) (%)	28.1% Excellent ↑ Excellent Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Above avg (+134%)	28.5% Excellent ↑ Excellent Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Above avg (+137%)	15.0% Fair ↑ Fair Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Above avg (+25%)	15.6% Good → Good Stable Net income as a percentage of revenue Optimal: > 15% vs Sector: Above avg (+30%)	17.7% Good ↑ Good Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Above avg (+47%)	7.0% Caution ↓ Caution Declining Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-41%)	19.9% Good ↓ Good Declining Net income as a percentage of revenue Optimal: > 15% vs Sector: Above avg (+66%)	20.4% Excellent Excellent Net income as a percentage of revenue Optimal: > 15% vs Sector: Above avg (+70%)	21.5% Excellent Excellent Net income as a percentage of revenue Optimal: > 15% vs Sector: Above avg (+79%)	—	—	—	—	—	—	—	—	—
FCF Margin (%) (%)	-9.1% Weak ↑ Weak Improving Free cash flow as a percentage of revenue Optimal: > 10%	-68.4% Weak ↓ Weak Declining Free cash flow as a percentage of revenue Optimal: > 10%	-18.8% Weak ↓ Weak Declining Free cash flow as a percentage of revenue Optimal: > 10%	46.7% Excellent ↑ Excellent Improving Free cash flow as a percentage of revenue Optimal: > 10%	26.3% Excellent ↑ Excellent Improving Free cash flow as a percentage of revenue Optimal: > 10%	-11.0% Weak ↓ Weak Declining Free cash flow as a percentage of revenue Optimal: > 10%	-1.6% Weak ↓ Weak Declining Free cash flow as a percentage of revenue Optimal: > 10%	28.1% Excellent Excellent Free cash flow as a percentage of revenue Optimal: > 10%	-13.7% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	—	—	—	—	—	—	—	—	—
FCF / Net Income (x)	-0.33x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	-2.40x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	-1.26x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	3.00x Excellent ↑ Excellent Improving Free cash flow relative to reported net income Optimal: > 1x	1.49x Good ↑ Good Improving Free cash flow relative to reported net income Optimal: > 1x	-1.57x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	-0.08x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	1.38x Good Good Free cash flow relative to reported net income Optimal: > 1x	-0.64x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	—	—	—	2.38x Excellent Excellent Free cash flow relative to reported net income Optimal: > 1x	0.00x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	—	—	0.10x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	—

🎯 Is capital allocation efficient? 3 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Dec 31, 2023 10-Q ↗	Q2 FY2023 Dec 31, 2023 10-Q ↗	Q1 FY2023 Dec 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Dec 31, 2022 10-Q ↗	Q2 FY2022 Dec 31, 2022 10-Q ↗	Q1 FY2022 Dec 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗
Return on Invested Capital (%)	31.0% Excellent ↓ Excellent Declining Return earned on debt + equity capital invested Optimal: > 10%	53.1% Excellent ↓ Excellent Declining Return earned on debt + equity capital invested Optimal: > 10%	50.3% Excellent ↑ Excellent Improving Return earned on debt + equity capital invested Optimal: > 10%	41.0% Excellent ↑ Excellent Improving Return earned on debt + equity capital invested Optimal: > 10%	206.5% Excellent ↑ Excellent Improving Return earned on debt + equity capital invested Optimal: > 10%	-115.6% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-20.5% Weak → Weak Stable Return earned on debt + equity capital invested Optimal: > 10%	-22.7% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-39.6% Weak Weak Return earned on debt + equity capital invested Optimal: > 10%	0.0% Weak Weak Return earned on debt + equity capital invested Optimal: > 10%	—	—	—	13.3% Good Good Return earned on debt + equity capital invested Optimal: > 10%	—	—	—	—
Return on Capital (%) (%)	11.4% Good ↑ Good Improving Operating profit relative to total assets Optimal: > 10%	6.7% Caution ↑ Caution Improving Operating profit relative to total assets Optimal: > 10%	3.0% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	5.0% Caution ↑ Caution Improving Operating profit relative to total assets Optimal: > 10%	4.8% Caution Caution Operating profit relative to total assets Optimal: > 10%	3.5% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	—	—	0.0% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	—	—	—	—	—	—	—
Return on Common Equity (%) (%)	-61.8% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-512%)	-104.1% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-794%)	-22.7% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-251%)	-18.3% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-222%)	-16.5% Weak → Weak Stable Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-210%)	-6.2% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-142%)	-19.7% Weak → Weak Stable Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-231%)	-21.7% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-245%)	-37.9% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-353%)	0.0% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-100%)	—	—	—	10.0% Fair Fair Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-33%)	—	—	—	—

⚖️ Is the balance sheet risky? 4 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Dec 31, 2023 10-Q ↗	Q2 FY2023 Dec 31, 2023 10-Q ↗	Q1 FY2023 Dec 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Dec 31, 2022 10-Q ↗	Q2 FY2022 Dec 31, 2022 10-Q ↗	Q1 FY2022 Dec 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗
Debt to Equity (x)	-3.38x Excellent ↓ Excellent Declining Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-662%)	-2.96x Excellent ↓ Excellent Declining Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-593%)	-1.47x Excellent ↓ Excellent Declining Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-345%)	-1.20x Excellent ↓ Excellent Declining Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-300%)	-1.09x Excellent Excellent Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-282%)	-0.93x Excellent Excellent Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-256%)	—	—	—	—	—	—	—	—	—	—	—	—
Interest Coverage (x)	—	6.75x Good → Good Stable Operating income divided by interest expense Optimal: > 5x	4.78x Fair ↓ Fair Declining Operating income divided by interest expense Optimal: > 5x	8.00x Good ↑ Good Improving Operating income divided by interest expense Optimal: > 5x	7.33x Good ↓ Good Declining Operating income divided by interest expense Optimal: > 5x	4.60x Fair ↓ Fair Declining Operating income divided by interest expense Optimal: > 5x	10.71x Excellent → Excellent Stable Operating income divided by interest expense Optimal: > 5x	10.71x Excellent Excellent Operating income divided by interest expense Optimal: > 5x	10.71x Excellent Excellent Operating income divided by interest expense Optimal: > 5x	—	—	—	—	—	—	—	—	—
Net Debt (USD)	$311.00M	$95.00M	$-141.00M	$-202.00M	$-61.00M	$-4.00M	—	—	—	—	—	—	—	—	—	—	—	—
Debt / EBITDA (x)	3.50x Caution ↓ Caution Declining Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	3.49x Caution ↓ Caution Declining Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	6.61x Weak ↑ Weak Improving Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	4.16x Weak ↓ Weak Declining Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	4.38x Weak Weak Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	6.18x Weak Weak Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	—	—	—	—	—	—	—	—	—	—	—	—

📊 What does each share earn? 6 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Dec 31, 2023 10-Q ↗	Q2 FY2023 Dec 31, 2023 10-Q ↗	Q1 FY2023 Dec 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Dec 31, 2022 10-Q ↗	Q2 FY2022 Dec 31, 2022 10-Q ↗	Q1 FY2022 Dec 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗
Revenue per Share (USD)	$2.56	—	$2.51	$2.42	$2.15	—	$2.33	$2.21	$2.09	—	—	—	—	—	—	—	—	—
Basic EPS, GAAP (USD)	$0.71	$0.81	$0.34	$0.15	$0.38	$0.16	$0.16	$-0.72	$0.45	$0.00	$0.00	$0.00	$-0.92	$-0.02	$0.00	$0.00	$-0.30	—
Free Cash Flow per Share (USD)	$-0.23	—	$-0.47	$1.13	$0.56	—	$-0.04	$0.62	$-0.29	—	—	—	—	—	—	—	—	—
Book Value per Share (USD)	$-1.16	—	$-1.66	$-2.06	$-2.30	—	$-2.35	$-2.08	$-1.18	—	—	—	—	—	—	—	—	—
Tangible Book Value per Share (USD)	$-1.16	—	$-1.66	$-2.06	$-2.30	—	$-2.35	$-2.08	$-1.18	—	—	—	—	—	—	—	—	—
Basic Weighted Avg Shares (shares)	124.00M	—	125.00M	125.00M	124.00M	—	132.00M	135.00M	136.00M	—	—	—	—	—	—	—	—	—

🏦 How resilient is the balance sheet? 3 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Dec 31, 2023 10-Q ↗	Q2 FY2023 Dec 31, 2023 10-Q ↗	Q1 FY2023 Dec 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Dec 31, 2022 10-Q ↗	Q2 FY2022 Dec 31, 2022 10-Q ↗	Q1 FY2022 Dec 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗
Working Capital (USD)	$-112.00M	$-262.00M	$-43.00M	$-105.00M	$-122.00M	$-97.00M	—	—	—	$-24.00M	—	—	—	—	—	—	—	—
LT Debt (USD)	$486.00M	$290.00M	$304.00M	$308.00M	$311.00M	$315.00M	—	—	—	—	—	—	—	—	—	—	—	—
Total Equity (USD)	$-144.00M	$-98.00M	$-207.00M	$-257.00M	$-285.00M	$-337.00M	$-310.00M	$-281.00M	$-161.00M	$-184.00M	—	—	—	$-20.00M	—	—	—	$121.00M

📋 What is driving earnings? 4 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Dec 31, 2023 10-Q ↗	Q2 FY2023 Dec 31, 2023 10-Q ↗	Q1 FY2023 Dec 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Dec 31, 2022 10-Q ↗	Q2 FY2022 Dec 31, 2022 10-Q ↗	Q1 FY2022 Dec 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗
Sales/Revenue/Turnover (USD)	$317.00M	$358.00M	$314.00M	$302.00M	$266.00M	$299.00M	$307.00M	$299.00M	$284.00M	—	—	—	—	—	—	—	—	—
Depreciation Expense (USD)	$2.00M	$2.00M	$3.00M	$2.00M	$5.00M	$5.00M	$4.00M	$2.00M	$5.00M	—	—	—	—	—	—	—	—	—
Net Income, GAAP (USD)	$89.00M	$102.00M	$47.00M	$47.00M	$47.00M	$21.00M	$61.00M	$61.00M	$61.00M	$0.00	$0.00	$0.00	$-126.00M	$-2.00M	$0.00	$0.00	$-42.00M	—
Operating Cash Flow (USD)	$-9.00M	$-221.00M	$-39.00M	$158.00M	$75.00M	$-17.00M	$2.00M	$88.00M	$-37.00M	$0.00	$0.00	$0.00	$-300.00M	$0.00	$0.00	$0.00	$-4.00M	—

⌨️ Keyboard Shortcuts

/ Search

Esc Clear

A Annual

Q Quarterly

1-7 Jump to category

R Reset

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 5 years · 18 quarters

Indivior Pharmaceuticals, Inc.

Analytical Summary

18-Year Financial Trajectory

Bullish Indicators

Bearish Risks

Health Breakdown

Statement lens

Benchmark Lens

Signals

Percentile Rankings

Peer Comparison

Compare INDV with peers